Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 09077A106 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
CVI Investments, Inc.
13G/A
Amendment 2
|
9.9% |
2/17/2026
Event 12/31/2025
|
|
| CVI Investments, Inc. | 9.9% | ||
| Heights Capital Management, Inc. | 9.9% | ||
| Blue Owl Capital Holdings LP 13G | 5.9% |
2/12/2026
Event 12/31/2025
|
|
| Rainer M. Erdtmann 13G/A Amendment 4 | 3.9% |
2/6/2026
Event 12/31/2025
|
|
| Janus Henderson Group PLC 13G | 5.0% |
12/8/2025
Event 11/28/2025
|
|
| Blue Owl Capital Holdings LP 13G/A Amendment 1 | 3.4% |
11/14/2025
Event 9/30/2025
|
|
|
CVI Investments, Inc.
13G/A
Amendment 1
|
9.9% |
11/7/2025
Event 9/30/2025
|
|
| CVI Investments, Inc. | 9.9% | ||
| Heights Capital Management, Inc. | 9.9% | ||
|
Cormorant Asset Management, LP
13D/A
Amendment 4
|
1.5% |
10/24/2025
Event 10/22/2025
|
|
| Cormorant Global Healthcare Master Fund, LP | 0.7% | ||
| Cormorant Global Healthcare GP, LLC | 0.7% | ||
| Cormorant Private Healthcare Fund III LP | 0.7% | ||
| Cormorant Private Healthcare GP III, LLC | 0.7% | ||
| Cormorant Asset Management, LP | 1.4% | ||
| Chen Bihua | 1.5% | ||
|
Cormorant Asset Management, LP
13D/A
Amendment 3
|
5.3% |
10/10/2025
Event 10/8/2025
|
|
| Cormorant Global Healthcare Master Fund, LP | 2.6% | ||
| Cormorant Global Healthcare GP, LLC | 2.6% | ||
| Cormorant Private Healthcare Fund III LP | 2.5% | ||
| Cormorant Private Healthcare GP III, LLC | 2.5% | ||
| Cormorant Asset Management, LP | 5.2% | ||
| Chen Bihua | 5.3% | ||
|
Rainer M. Erdtmann
13G/A
Amendment 3
|
5.2% |
8/13/2025
Event 6/30/2025
|
|
| Rainer M. Erdtmann | 5.2% | ||
| Point Sur Investors, LLC | 0.8% | ||
| Point Sur Investors Fund I, L.P. | 0.4% | ||
| Blue Owl Capital Holdings LP 13G | 6.1% |
8/11/2025
Event 6/30/2025
|
|
|
Cormorant Asset Management, LP
13D/A
Amendment 2
|
6.5% |
7/22/2025
Event 6/20/2025
|
|
| Cormorant Global Healthcare Master Fund, LP | 3.2% | ||
| Cormorant Global Healthcare GP, LLC | 3.2% | ||
| Cormorant Private Healthcare Fund III LP | 3.0% | ||
| Cormorant Private Healthcare GP III, LLC | 3.0% | ||
| Cormorant Asset Management, LP | 6.3% | ||
| Chen Bihua | 6.5% | ||
| BlackRock, Inc. 13G/A Amendment 1 | 1.3% |
7/16/2025
Event 6/30/2025
|
|
|
CVI Investments, Inc.
13G
|
9.9% |
6/25/2025
Event 6/17/2025
|
|
| CVI Investments, Inc. | 9.9% | ||
| Heights Capital Management, Inc. | 9.9% | ||
|
Baker Bros. Advisors LP
13G/A
Amendment 2
|
4.0% |
2/14/2025
Event 12/31/2024
|
|
| Baker Bros. Advisors LP | 4.0% | ||
| Baker Bros. Advisors (GP) LLC | 4.0% | ||
| Julian C. Baker | 4.0% | ||
| Felix J. Baker | 4.0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 67 | 25.3 M | $36.8 M |
| 2026 Q1 | 70 | 24.4 M | $37.3 M |
| 2025 Q4 | 68 | 23.2 M | $28.8 M |
| 2025 Q3 | 84 | 26.5 M | $53.5 M |
| 2025 Q2 | 99 | 28.8 M | $51.8 M |
| 2025 Q1 | 109 | 21.4 M | $47.2 M |
| 2024 Q4 | 128 | 23.0 M | $89.3 M |
| 2024 Q3 | 106 | 23.5 M | $237 M |
| 2024 Q2 | 122 | 24.1 M | $108 M |
| 2024 Q1 | 127 | 32.1 M | $480 M |
| 2023 Q4 | 117 | 28.6 M | $415 M |
| 2023 Q3 | 95 | 30.1 M | $414 M |
| 2023 Q2 | 114 | 29.6 M | $649 M |
| 2023 Q1 | 89 | 23.4 M | $727 M |
| 2022 Q4 | 59 | 14.5 M | $122 M |
| 2022 Q3 | 52 | 17.6 M | $172 M |
| 2022 Q2 | 43 | 17.0 M | $204 M |
| 2022 Q1 | 52 | 18.3 M | $81.7 M |
| 2021 Q4 | 50 | 17.1 M | $127 M |
| 2021 Q3 | 40 | 17.1 M | $205 M |
| 2021 Q2 | 46 | 16.6 M | $256 M |